DELAYED-RELEASE DIMETHYL FUMARATE-ASSOCIATED LYMPHOPENIA

被引：0
|
作者：
Chan, Andrew [1 ]
Fox, Robert J. [2 ]
Bar-Or, Amit [3 ,4 ]
Chen, Chongshu [5 ]
Fam, Sami [5 ]
Gold, Ralf [1 ]
Hanna, Jerome [5 ]
Mehta, Devangi [5 ]
Phillips, J. Theodore [6 ]
机构：
[1] Univ Bern, Bern Univ Hosp, Inselspital, Bern, Switzerland
[2] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[3] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[4] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[5] Biogen, Cambridge, MA USA
[6] Baylor Inst Immunol Res, Dallas, TX USA
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2019年 / 90卷 / 12期
关键词：
D O I：
10.1136/jnnp-2019-ABN-2.146
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
159
引用
收藏
页码：E53 / E53
页数：1
相关论文
共 50 条
  • [31] COMPARATIVE EFFECTIVENESS OF DELAYED-RELEASE DIMETHYL FUMARATE VERSUS FINGOLIMOD AND TERIFLUNOMIDE ON RISK OF RELAPSE
    Nicholas, Jacqueline
    Boster, Aaron
    Wu, Ning
    Huang, Ming-Yi
    Riester, Katherine
    Jhaveri, Mehul
    Edwards, Michael
    Lee, Andrew
    NEUROLOGY, 2017, 88
  • [32] Pregnancy outcomes with delayed-release dimethyl fumarate: interim results from an international registry
    Everage, N. J.
    Liu, S.
    Yun, J.
    Prada, C.
    Hanna, J.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 914 - 915
  • [33] Pregnancy outcomes from an international registry of patients treated with delayed-release dimethyl fumarate
    Everage, N. J.
    Jones, C. C.
    Hellwig, K.
    Rog, D.
    Liu, S.
    Mou, J.
    Prada, C.
    Hanna, J.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 295 - 295
  • [34] Tolerability and Pharmacokinetics of Delayed-Release Dimethyl Fumarate Administered With and Without Aspirin in Healthy Volunteers
    Sheikh, Sarah I.
    Nestorov, Ivan
    Russell, Heidy
    O'Gorman, John
    Huang, Ron
    Milne, Ginger L.
    Scannevin, Robert H.
    Novas, Mark
    Dawson, Katherine T.
    CLINICAL THERAPEUTICS, 2013, 35 (10) : 1582 - 1594
  • [35] Management Strategies to Facilitate Optimal Outcomes for Patients Treated with Delayed-release Dimethyl Fumarate
    Mayer, Lori
    Fink, Mary Kay
    Sammarco, Carrie
    Laing, Lisa
    DRUG SAFETY, 2018, 41 (04) : 347 - 356
  • [36] Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study
    Douglas L. Arnold
    Ralf Gold
    Ludwig Kappos
    Amit Bar-Or
    Gavin Giovannoni
    Krzysztof Selmaj
    Minhua Yang
    Ray Zhang
    Monica Stephan
    Sarah I. Sheikh
    Katherine T. Dawson
    Journal of Neurology, 2014, 261 : 1794 - 1802
  • [37] Dimethyl fumarate associated lymphopenia in clinical practice
    Longbrake, Erin E.
    Cross, Anne H.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (06) : 796 - 797
  • [38] Radiological findings suggest long-term treatment with delayed-release dimethyl fumarate is associated with tissue and axonal preservation
    Arnold, D. L.
    Kappos, L.
    Gold, R.
    Chen, C.
    Yang, L.
    Miller, C.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 288 - 289
  • [39] Dimethyl fumarate-associated transient bone marrow oedema syndrome
    Triplett, James
    Vijayan, Srimathy
    Prince, Richard
    Kermode, Allan
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (06) : 876 - 879
  • [40] Efficacy of delayed-release dimethyl fumarate for RRMS in prior interferon users in the DEFINE and CONFIRM studies
    Fernandez, O.
    Giovannoni, G.
    Fox, R. J.
    Gold, R.
    Phillips, J. T.
    Okwuokenye, M.
    Zhang, A.
    Kurukulasuriya, N. C.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 96 - 96
12345